ABBV-303
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-303, covering 2025-10-27 to 2025-10-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors [Phase 1]